These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 30562421)

  • 1. Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study.
    Burisch J; Zammit SC; Ellul P; Turcan S; Duricova D; Bortlik M; Andersen KW; Andersen V; Kaimakliotis IP; Fumery M; Gower-Rousseau C; Girardin G; Valpiani D; Goldis A; Brinar M; Čuković-Čavka S; Oksanen P; Collin P; Barros L; Magro F; Misra R; Arebi N; Eriksson C; Halfvarson J; Kievit HAL; Pedersen N; Kjeldsen J; Myers S; Sebastian S; Katsanos KH; Christodoulou DK; Midjord J; Nielsen KR; Kiudelis G; Kupcinskas L; Nikulina I; Belousova E; Schwartz D; Odes S; Salupere R; Carmona A; Pineda JR; Vegh Z; Lakatos PL; Langholz E; Munkholm P;
    J Gastroenterol Hepatol; 2019 Jun; 34(6):996-1003. PubMed ID: 30562421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN.
    Aloi M; Birimberg-Schwartz L; Buderus S; Hojsak I; Fell JM; Bronsky J; Veereman G; Koletzko S; Shaoul R; Miele E; Turner D; Russell RK
    Inflamm Bowel Dis; 2016 Jun; 22(6):1378-83. PubMed ID: 27135479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of inflammatory bowel disease unclassified: a case-control study.
    Shao Y; Zhao Y; Lv H; Yan P; Yang H; Li J; Li J; Qian J
    BMC Gastroenterol; 2024 Mar; 24(1):105. PubMed ID: 38481157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of inflammatory bowel disease and phenotype at diagnosis in 2011: results of the Epi-IBD 2011 study in the Vigo area.
    Hernández V; de Castro ML; Salinas-Rojo M; Fernández A; Martínez-Ares D; Sanromán L; Pineda JR; Carmona A; Salgado-Álvarez C; Martínez-Cadilla J; Pereira S; García-Burriel JI; González-Portela C; Vázquez S; Rodríguez-Prada JI;
    Rev Esp Enferm Dig; 2022 Feb; 114(2):103-106. PubMed ID: 34154368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Bowel Disease-Unclassified in Children: Diagnosis and Pharmacological Management.
    D'Arcangelo G; Aloi M
    Paediatr Drugs; 2017 Apr; 19(2):113-120. PubMed ID: 28150131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short noncoding RNAs as predictive biomarkers for the development from inflammatory bowel disease unclassified to Crohn's disease or ulcerative colitis.
    James JP; Riis LB; Søkilde R; Malham M; Høgdall E; Langholz E; Nielsen BS
    PLoS One; 2024; 19(2):e0297353. PubMed ID: 38408066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
    Henriksen M; Jahnsen J; Lygren I; Sauar J; Schulz T; Stray N; Vatn MH; Moum B;
    Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort.
    Vegh Z; Burisch J; Pedersen N; Kaimakliotis I; Duricova D; Bortlik M; Vinding KK; Avnstrøm S; Olsen J; Nielsen KR; Katsanos KH; Tsianos EV; Lakatos L; Schwartz D; Odes S; D'Incà R; Beltrami M; Kiudelis G; Kupcinskap L; Jucov A; Turcan S; Barros LF; Magro F; Lazar D; Goldis A; de Castro L; Hernandez V; Niewiadomski O; Bell S; Langholz E; Munkholm P; Lakatos PL;
    J Crohns Colitis; 2015 Sep; 9(9):747-53. PubMed ID: 26055976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo Crohn's Disease after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis and Inflammatory Bowel Disease Unclassified: Long-Term Follow-Up of a Prospective Inflammatory Bowel Disease Registry.
    Zaghiyan K; Kamiński JP; Barmparas G; Fleshner P
    Am Surg; 2016 Oct; 82(10):977-981. PubMed ID: 27779987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of Diagnostic Criteria for IBD Subtypes Including IBD-unclassified in Children: a Multicentre Study From the Pediatric IBD Porto Group of ESPGHAN.
    Birimberg-Schwartz L; Zucker DM; Akriv A; Cucchiara S; Cameron FL; Wilson DC; Lazowska I; Yianni L; Paul SP; Romano C; Kolacek S; Buderus S; Pærregaard A; Russell RK; Escher JC; Turner D;
    J Crohns Colitis; 2017 Sep; 11(9):1078-1084. PubMed ID: 28430891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype of inflammatory bowel disease at diagnosis in the Netherlands: a population-based inception cohort study (the Delta Cohort).
    Nuij VJ; Zelinkova Z; Rijk MC; Beukers R; Ouwendijk RJ; Quispel R; van Tilburg AJ; Tang TJ; Smalbraak H; Bruin KF; Lindenburg F; Peyrin-Biroulet L; van der Woude CJ;
    Inflamm Bowel Dis; 2013 Sep; 19(10):2215-22. PubMed ID: 23835444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].
    Martín de Carpi J; Vila V; Varea V
    An Pediatr (Barc); 2011 Oct; 75(4):232-8. PubMed ID: 21549650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
    Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study.
    Fernández A; Hernández V; Martínez-Ares D; Sanromán L; de Castro ML; Pineda JR; Carmona A; González-Portela C; Salgado C; Martínez-Cadilla J; Pereira S; García-Burriel JI; Vázquez S; Rodríguez-Prada I;
    Gastroenterol Hepatol; 2015 Nov; 38(9):534-40. PubMed ID: 25890448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease unclassified.
    Zhou N; Chen WX; Chen SH; Xu CF; Li YM
    J Zhejiang Univ Sci B; 2011 Apr; 12(4):280-6. PubMed ID: 21462383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort.
    Burisch J; Pedersen N; Cukovic-Cavka S; Turk N; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup Jens F; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Bailey Y; O'Morain C; Schwartz D; Odes S; Martinato M; Lombardini S; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Hernandez V; Almer S; Zhulina Y; Halfvarson J; Tsai HH; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Inflamm Bowel Dis; 2014 Jan; 20(1):36-46. PubMed ID: 24252978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients.
    Everhov ÅH; Sachs MC; Malmborg P; Nordenvall C; Myrelid P; Khalili H; Elmberg M; Ekbom A; Askling J; Jakobsson G; Halfvarson J; Ludvigsson JF; Olén O
    Scand J Gastroenterol; 2019 Jan; 54(1):55-63. PubMed ID: 30700170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile and Very Early Onset Inflammatory Bowel Disease: A Multicenter Study.
    Guz-Mark A; Aloi M; Scarallo L; Bramuzzo M; Escher JC; Alvisi P; Henderson P; Hojsak I; Lev-Tzion R; El-Matary W; Schwerd T; Granot M; Sladek M; Strisciuglio C; Müller KE; Olbjørn C; Tzivinikos C; Yerushalmy-Feler A; Huysentruyt K; Norsa L; Viola I; de Ridder L; Shouval DS; Lega S; Lionetti P; Catassi G; Assa A;
    Pediatrics; 2024 Aug; 154(2):. PubMed ID: 39015095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.